Interestingly, data proved the higher dual targeting property of LDP 14 in the human U87 glioma more than SRLL, SRLC, TGN, and even Lep 30 (P ≤ 0.001) (Figure 3B). This evidence concerns the gene LEP and central nervous system cancer.